COVID-19: Which Drug, When, and Why? Anti-inflammatory Agents and Immunomodulators
In which patients with COVID-19 should we use anti-inflammatory agents and immunomodulators? Hear expert insights on the timing and role of convalescent plasma, corticosteroids, IL-6 inhibitors, and JAK inhibitors in the treatment of COVID-19.
Decera Clinical Education Infectious Disease Podcast · Vikramjit Mukherjee MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Anti-inflammatory agents and immunomodulators are key components to treating patients who are severely or critically ill due to a COVID-19 infection.
In this episode, Vikramjit Mukherjee, MD, discusses the role and timing of these treatment options, including:
- High-titer convalescent plasma
- Corticosteroids
- Interleukin-6 inhibitors (eg, tocilizumab)
- Janus kinase inhibitors (eg, baricitinib)
Presenter:
Vikramjit Mukherjee, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York
Review the downloadable slidesets at:
https://bit.ly/35NNb7Q
Link to full program:
https://bit.ly/35SrxQ0
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.